Location History:
- Kashiwara, JP (2000)
- Osaka-fu, JP (1998 - 2001)
- Osakasayama, JP (2013)
- Osaka, JP (1995 - 2018)
- Kawachinagano, JP (2013 - 2019)
Company Filing History:
15 out of 906 
4 out of 182 
3 out of 76 
Years Active: 1995-2019
Title: The Innovations of Koji Tanaka: A Renowned Inventor in Oncology
Introduction
Koji Tanaka, based in Osaka, Japan, is a distinguished inventor with a remarkable portfolio of 25 patents mainly focused on anticancer agents. His work has significantly contributed to the field of oncology, providing innovative solutions with an emphasis on safety and efficacy.
Latest Patents
Among Tanaka's latest inventions is an anticancer agent comprising an aminoacetonitrile compound as an active ingredient. This invention is characterized by its high safety profile and superior anticancer activity. The formulation involves a complex structure defined by specific chemical components, ensuring effectiveness against cancer while minimizing adverse effects. The detailed structure of the compound includes various substituents and functional groups that enhance its pharmacologic properties, making it a noteworthy advancement in cancer treatment.
Career Highlights
Throughout his career, Koji Tanaka has made significant strides in pharmaceutical development. He has had the opportunity to work with prominent companies such as Tsubakimoto Chain Company and Nihon Nohyaku Co., Ltd., where he honed his expertise in drug formulation and innovation. His contributions to these organizations have been instrumental in advancing cancer treatment options, highlighting his role as a key figure in the industry.
Collaborations
Tanaka's journey has also included collaborations with esteemed colleagues, including Masatsugu Oda and Akiyuki Suwa. These partnerships have fostered a collaborative environment that encourages innovation and the exchange of ideas, further enhancing the impact of their collective work in the field of oncology.
Conclusion
In conclusion, Koji Tanaka stands out as a pivotal inventor in the realm of anticancer therapies. His innovative contributions, demonstrated through his extensive patent portfolio and collaborative efforts, reflect a deep commitment to improving patient outcomes in cancer treatment. His work continues to inspire future generations of inventors and researchers dedicated to fighting cancer.